Aller au contenu
Black Friday — 30% OFFLivraison gratuite dès 99 € d’achat
  1. Accueil
  2. Récupération et régénération
  3. Myostatin 1mg
Récupération

Myostatin 1mg

MIP-7 (Myostatin Inhibitory Peptide 7) is a synthetic 24-amino-acid, C-terminally amidated peptide (AWRQNTRYSRIEAIKIQILSKLRL-NH2) derived from the N-terminal α-helical region of the mouse myostatin prodomain.

Conditionnement: Myostatin 1mg.

Sélectionnez le dosage et le conditionnement souhaités.

Conditionnement illustratif généré par IA.

Conditionnement
Le prix initial était : 133,98 €.Le prix actuel est : 93,79 €.

Disponible sur demande en France

Demander à un conseiller
Un conseiller vous contacte et la pharmacie partenaire vérifie si et comment la demande peut aboutir. Une ordonnance valide, ou une évaluation par un service de télémédecine autorisé, peut être nécessaire.
  • Pharmacie partenaire
  • Accompagnement personnalisé
  • Livraison discrète
  • Conditionnement
    Myostatin 1mg

Expédition et livraison

  • Expédition habituellement sous 24 heures après confirmation du paiement.
  • USPS Regular Shipping · 11,95 € · Env. 3–5 jours ouvrés
  • FedEx 2 Days Delivery · 28,99 € · Env. 2 jours ouvrés
  • FedEx Overnight Delivery · 40,99 € · Env. 1 jour ouvré

Réservé à la recherche en laboratoire.

Ne pas utiliser chez l’être humain ou l’animal.

Composition et détails du produit

Présentation

MIP-7 (Myostatin Inhibitory Peptide 7) is a synthetic 24-amino-acid, C-terminally amidated peptide (AWRQNTRYSRIEAIKIQILSKLRL-NH2) derived from the N-terminal α-helical region of the mouse myostatin prodomain. In the native latent complex, this region of the prodomain helps hold mature myostatin (GDF-8) in an inactive state.

MIP-7 was developed to reproduce that inhibitory interaction in a short, synthetically accessible sequence. It is not myostatin itself and does not activate the myostatin pathway. It is studied as a myostatin antagonist, binding the mature growth factor and reducing its ability to signal through activin type II receptors (ACVR2A/ACVR2B) and downstream Smad2/3.

Research applications include myostatin inhibition studies, prodomain–ligand interaction research, structure–activity work on peptide-based TGF-β superfamily antagonists, and muscle biology models where myostatin signalling is suppressed.

  • High Purity – 99% Purity Guaranteed
  • Independently Lab Tested
  • Research Grade Quality
  • For Laboratory Research Use Only

Données moléculaires sur PubChem

Myostatin 1mg1 vial | KIT (10 vials)

Propriétés

Chemical Formula C133H227N43O33
Synonyms 1621169-52-5, Myostatin inhibitory peptide 7, U8DGS69FVC Ala-Trp-Arg-Gln-Asn-Thr-Arg-Tyr-Ser-Arg-Ile-Glu-Ala-Ile-Lys-Ile-Gln-Ile-Leu-Ser-Lys-Leu-Arg-Leu-NH2, UNII-U8DGS69FVC, CHEMBL3410227, L-Alanyl-L-tryptophyl-L-arginyl-L-glutaminyl-L-asparaginyl-L-threonyl-L-arginyl-L-tyrosyl-L-seryl-L-arginyl-L-isoleucyl-L-alpha-glutamyl-L-alanyl-L-isoleucyl-L-lysyl-L-isoleucyl-L-glutaminyl-L-isoleucyl-L-leucyl-L-seryl-L-lysyl-L-leucyl-L-arginyl-L-leucinamide, orb2563812
Molar Mass 2956.5 g/mol
CAS Number 1621169-52-5
PubChem CID 118732224
Formats disponibles 1 vial · KIT (10 vials)
Shelf Life 24 months

Recherche

Myostatin (GDF-8) is a TGF-β superfamily growth factor that negatively regulates skeletal muscle mass. It is synthesised as a precursor and held in a latent state by its own prodomain, which shields the receptor-binding surfaces of the mature dimer. Peptides derived from the prodomain therefore represent a direct route to myostatin inhibition.

MIP-7 comes out of structure–activity work by Takayama and colleagues (J Med Chem, 2015), which narrowed the mouse myostatin prodomain down to a minimum inhibitory sequence and then refined it. Follow-up structural studies indicate the peptide adopts an α-helical conformation and interacts with mature myostatin in a way that interferes with receptor engagement.

MIP-7 is used in vitro to inhibit myostatin-induced Smad2/3 signalling and reporter activity, typically alongside recombinant myostatin as the activating ligand. Additional applications include comparison against other myostatin inhibitors (follistatin, soluble ACVR2B, antibodies), investigation of prodomain-mediated latency, and design of next-generation peptide antagonists.

Independently third-party HPLC-tested; COA available per batch.

FAQ

Is MIP-7 the same as myostatin (GDF-8)?

No. Myostatin (GDF-8) is a ~25 kDa homodimeric growth factor that activates the ACVR2B/Smad2/3 pathway. MIP-7 is a 24-residue synthetic peptide (2956.5 g/mol) derived from the myostatin prodomain, and it is studied as an inhibitor of myostatin rather than an activator.

What is the primary research use of MIP-7?

MIP-7 is used to inhibit myostatin activity in experimental systems. A common design pairs recombinant myostatin (to activate Smad2/3 signalling) with MIP-7 to measure how effectively the peptide suppresses that response, using reporter assays, Smad2/3 phosphorylation or downstream transcriptional readouts.

What controls are important in MIP-7 experiments?

Common controls include vehicle-only samples for baseline, myostatin-only samples to confirm pathway activation, a scrambled or inactive peptide to rule out non-specific effects, and an established myostatin inhibitor (such as follistatin or a neutralising antibody) as a benchmark for inhibition.

Le prix initial était : 133,98 €.Le prix actuel est : 93,79 €.